Capricor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.

About CAPR

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. 

CEO
Linda Marbán
CEOLinda Marbán
Employees
160
Employees160
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1996
Founded1996
Employees
160
Employees160

CAPR Key Statistics

Market cap
596.54M
Market cap596.54M
Price-Earnings ratio
-11.09
Price-Earnings ratio-11.09
Dividend yield
Dividend yield
Average volume
1.41M
Average volume1.41M
High today
$13.20
High today$13.20
Low today
$12.59
Low today$12.59
Open price
$13.12
Open price$13.12
Volume
935.94K
Volume935.94K
52 Week high
$23.40
52 Week high$23.40
52 Week low
$3.52
52 Week low$3.52

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.